Pei-Chieh Fong

Pei-Chieh Fong is the Vice President, Medical for AstraZeneca and currently leads more than 75 countries across Asia, Middle East and Africa, Latin America, Australia, and Russia. Pei-Chieh is focused on transforming health outcomes through innovation, leveraging transformative science to bring life-changing medications and treatments to patients. During her career at AstraZeneca, Pei-Chieh has covered the entire range of diseases and molecules and previously lead the International Oncology team. Prior to joining AstraZeneca, Pei-Chieh held roles at Roche, Pfizer, and Novartis, covering areas including infectious disease, cardiovascular diseases, immunology as well as oncology.

Latest Articles

Opinion: The NCD toll is deeply inequitable and requires rapid action

over 2 years ago // Sponsored by AstraZeneca

Facing a shocking rise in noncommunicable diseases, we need a holistic approach that encompasses health equity, scalable solutions, and a shift to view health care as an investment.

Opinion: Working in partnership to improve health equity

about 3 years ago // Sponsored by AstraZeneca

With the COVID-19 pandemic further exacerbating the health care disparities felt in LMICs, partnerships and digital solutions will be crucial to achieving health equity. AstraZeneca’s Nick Passey, Cindy Hoots, and Pei-Chieh Fong offer their perspective.

Opinion: A cancer revolution is on the cusp — if equity is improved

over 3 years ago // Sponsored by AstraZeneca

While cancer treatment developments are moving quickly, quality care is only available in 15% of low- and middle-income countries. VP Oncology International's Ti Hwei and VP Medical International Pei-Chieh stress the need to address barriers to equitable access.

See all articles by Pei-Chieh Fong